Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures, On the topic of Direct funding, subsidies and incentives for the development… Continue Reading →
Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures On the topic of Transparency, cost benefit analysis and de-linkage of cost… Continue Reading →
In 2007, Thailand was involved in a dispute over the granting of compulsory licenses on medicines, including the patents used for Kaletra, an Abbott drug used in the treatment of AIDS. Kaletra is the brand name for a fixed dose combination of lopinavir and ritonavir (LPV/r) — two drugs invented at Abbott on an NIH grant. In 2007, LPV/r was the preferred combination for protease inhibitor regimes used to treat AIDS. Continue Reading →
This note concerns two areas of policy concerning humanitarian uses of patents. (1), a recommended exception to patent rights for humanitarian uses, and (2), the licensing of patents for humanitarian uses. Both examples focus on access to essential medical technologies.… Continue Reading →
Press Release 15 Feb 07 FMI James Love +1.202.332.2670, cell +1.202.361.3040, james.love@keionline.org September 2, 2009 (See attachment for patent and health experts contact information) FTC ASKED TO INVESTIGATE GILEAD EFFORT TO CONTROL MARKET FOR AIDS DRUGS INGREDIENTS [Complaint available… Continue Reading →
WHO website on the EWG NEWS: The EWG secretariat has released a draft evaluation framework, evaluation criteria and the inventory of financing proposals. The EWG is accepting public comments through the Second Web-based Public Hearing. Deadline: September 5 2009. KEI… Continue Reading →
Original at: https://tacd.org/wp-content/uploads/2013/09/TACD-IP-07-09-IP-Aspects-of-Pandemics.pdf Resolution on Intellectual Property Aspects of Pandemics DOC No. IP 07-09 DATE ISSUED: May 2009 Introduction In recent years there have been several cases of possible new pandemics of infectious diseases. This includes recently concerns about SARS,… Continue Reading →
Romulus
Although the founding of Rome is a mystery, the myths of its origin hold that Romulus and Remus, the sons of Mars and Rhea Silvia, abandoned by their parents on the banks of the river Tiber, were suckled by a she-wolf, Lupa. Upon reaching adulthood, Romulus and Remus vied for control of Rome. According to Wikipedia,
Continue Reading →
We have received a copy of an amendment to the September 2006 voluntary License Agreement between Gilead Sciences, Inc and Ranbaxy Laboratories, Ltd concerning the manufacture and sale of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine for the treatment of HIV-AIDS.
Continue Reading →
https://www.keionline.org/misc-docs/b_b_igwg/working_document_barbados_bolivia.pdf April 2008 According to resolution WHA60.30 on Public Health, Innovation and Intellectual Property, the Director-General of the WHO is asked: (4) to encourage the development of proposals for health-needs driven research and development for discussion at the Intergovernmental Working… Continue Reading →
